Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0WW5X
|
||||
Former ID |
DNC013801
|
||||
Drug Name |
N-Octylcarbamic Acid Biphenyl-3-yl Ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529498] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H27NO2
|
||||
Canonical SMILES |
CCCCCCCCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2
|
||||
InChI |
1S/C21H27NO2/c1-2-3-4-5-6-10-16-22-21(23)24-20-15-11-14-19(17-20)18-12-8-7-9-13-18/h7-9,11-15,17H,2-6,10,16H2,1H3,(H,22,23)
|
||||
InChIKey |
ZVIQRVAPSQCQGM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.